<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in" exact="Cameroon" post="following exposure to Raltegravir: lessons and implications in the"/>
 <result pre="Keywords HIV drug resistance Integrase inhibitors Protease inhibitors Viral tropism" exact="Cameroon" post="Funding Chantal Biya International Reference center for research on"/>
 <result pre="essentially) remains sub-optimal [1, 2]. ART program was launched in" exact="Cameroon" post="by May 2003, and genotyping drug resistance testing (GRT)"/>
 <result pre="of DRV/r and DTG efficacies. Of note, previous report from" exact="Cameroon" post="showed a case of successful raltegravir-containing ART for managing"/>
 <result pre="case surveillance should be required even in resource-limited settings like" exact="Cameroon" post="[18]. Conclusion In the era of transition to DTG-based"/>
 <result pre="the care and monitoring of this patient. We thank Michael" exact="Jordan" post="for a thorough review of this manuscript prior to"/>
 <result pre="transcriptase genotyping assay in CameroonArch Virol201115671235124310.1007/s00705-011-0982-321465085 11.Fokam J, Bellocchi MC," exact="Armenia" post="D, et al. Next-generation sequencing provides an added value"/>
</results>
